Reduced hemolytic complement activity in the classical pathway (CH50) is a risk factor for poor clinical outcomes of patients with infections: a retrospective analysis of health insurance claims in Japan
经典途径溶血补体活性降低(CH50)是感染患者临床预后不良的危险因素:一项基于日本健康保险索赔数据的回顾性分析
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1601690
Koami, Hiroyuki; Furukawa, Yutaro; Hirota, Yuri; Sasaki, Akira; Ogawa, Hirotaka; Matsuoka, Ayaka; Shinada, Kota; Nakayama, Kento; Sakurai, Ryota; Iwanaga, Sachiko; Onohara, Takayuki; Narumi, Shogo; Koba, Mayuko; Mori, Hirotaka; Umemura, Yutaka; Yamakawa, Kazuma; Okamoto, Kohji; Sakamoto, Yuichiro